Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Albers

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Neurologic Clinics|February 28, 2007
Toxic neuropathies associated with pharmaceutic and industrial agentsZachary London, James W Albers
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2018
Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trialsJames W Albers, Ryan Jacobson
Muscle & Nerve|September 17, 2004
Porphyric neuropathyJames W Albers, John K Fink
Current Neurology and Neuroscience Reports|June 24, 2014
Diabetic neuropathy: mechanisms, emerging treatments, and subtypesJames W Albers, Rodica Pop-Busui
Neurologic Clinics|August 3, 2002
Electrodiagnostic approach to the patient with suspected peripheral polyneuropathyTheodore H Wein, James W Albers
Neurology|July 13, 2005
Pseudoneurotoxic diseaseHerbert H Schaumburg, James W Albers
Handbook of Clinical Neurology|November 14, 2015
Clinical description of toxic neuropathiesAnn A Little, James W Albers
Expert Review of Neurotherapeutics|October 9, 2009
Treatment of chronic inflammatory demyelinating polyneuropathyRyan L Kaplan, James W Albers
Diabetes Care|December 21, 2013
Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyCatherine L Martin, James W Albers, Rodica Pop-Busui, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Interventions for preventing neuropathy caused by cisplatin and related compoundsJames W Albers, Vinay Chaudhry, Guido Cavaletti, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Neurologic Clinics|February 28, 2007
Toxic neuropathies associated with pharmaceutic and industrial agentsZachary London, James W Albers
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 13, 2018
Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trialsJames W Albers, Ryan Jacobson
Muscle & Nerve|September 17, 2004
Porphyric neuropathyJames W Albers, John K Fink
Current Neurology and Neuroscience Reports|June 24, 2014
Diabetic neuropathy: mechanisms, emerging treatments, and subtypesJames W Albers, Rodica Pop-Busui
Neurologic Clinics|August 3, 2002
Electrodiagnostic approach to the patient with suspected peripheral polyneuropathyTheodore H Wein, James W Albers
Neurology|July 13, 2005
Pseudoneurotoxic diseaseHerbert H Schaumburg, James W Albers
Handbook of Clinical Neurology|November 14, 2015
Clinical description of toxic neuropathiesAnn A Little, James W Albers
Expert Review of Neurotherapeutics|October 9, 2009
Treatment of chronic inflammatory demyelinating polyneuropathyRyan L Kaplan, James W Albers
Diabetes Care|December 21, 2013
Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications studyCatherine L Martin, James W Albers, Rodica Pop-Busui, et al.
The Cochrane Database of Systematic Reviews|February 18, 2011
Interventions for preventing neuropathy caused by cisplatin and related compoundsJames W Albers, Vinay Chaudhry, Guido Cavaletti, et al.
Pageof 4